FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2216193733> ?p ?o ?g. }

• W2216193733 endingPage "677" @default.
• W2216193733 startingPage "672" @default.
• W2216193733 abstract "The objectives of this study were to compare the diagnostic potential of (68)Ga-Alfatide II with(18)F-FDG in differentiating between non-small cell lung cancer patients (NSCLC) and lung tuberculosis (TB) patients.Twenty-one NSCLC patients and 13 TB patients were recruited. PET/CT images using either (68)Ga-Alfatide II or (18)F-FDG were acquired in 2 consecutive days. SUV quantitative comparison, receiver-operating curve analysis, and comprehensive visual analysis were performed. The expression of the angiogenesis marker αvβ3 in NSCLC and TB primary lesions was analyzed by immunohistochemistry.The (68)Ga-Alfatide II SUVmax and SUVmean were significantly different in NSCLC and TB (P = 0.0001 and 0.0007, respectively). The area under the receiver-operating curve value of (68)Ga-Alfatide II SUVmax was significantly higher than that of (18)F-FDG (P = 0.038). The visual differentiation diagnostic specificity of (68)Ga-Alfatide II was 1.57-fold (84.62% vs. 53.85%) higher than that of (18)F-FDG. In the detection of NSCLC lymph nodes, (68)Ga-Alfatide II was superior in specificity (100% vs. 66.7%), whereas the sensitivity was greater with (18)F-FDG (87.5% vs. 75%). In TB lymph node detection, the false-positive rate of (68)Ga-Alfatide II was one-third (15.4%/46.2%) the value of (18)F-FDG. Additionally, (68)Ga-Alfatide II detected more metastases in the brain but less in the liver and the bone. The αvβ3 biomarker was specifically expressed in the cells and the neovasculature of NSCLC lesions.(68)Ga-Alfatide II is qualified for detecting NSCLC primary lesions and is superior to (18)F-FDG in distinguishing NSCLC from TB in primary lesions and suggestive lymph nodes. (68)Ga-Alfatide II is more likely to be capable of detecting brain metastasis, and (18)F-FDG is more likely to be capable of detecting liver and early-stage bone metastases." @default.
• W2216193733 created "2016-06-24" @default.
• W2216193733 creator A5001104996 @default.
• W2216193733 creator A5004896348 @default.
• W2216193733 creator A5010336803 @default.
• W2216193733 creator A5025270532 @default.
• W2216193733 creator A5032874414 @default.
• W2216193733 creator A5034845779 @default.
• W2216193733 creator A5056053058 @default.
• W2216193733 creator A5065124597 @default.
• W2216193733 creator A5072942807 @default.
• W2216193733 creator A5077599099 @default.
• W2216193733 creator A5083617985 @default.
• W2216193733 date "2015-12-30" @default.
• W2216193733 modified "2023-10-09" @default.
• W2216193733 title "Comparing the Diagnostic Potential of ⁶⁸Ga-Alfatide II and ¹⁸F-FDG in Differentiating Between Non–Small Cell Lung Cancer and Tuberculosis" @default.
• W2216193733 cites W1573363574 @default.
• W2216193733 cites W1951726892 @default.
• W2216193733 cites W2000082608 @default.
• W2216193733 cites W2007634422 @default.
• W2216193733 cites W2008664891 @default.
• W2216193733 cites W2008766422 @default.
• W2216193733 cites W2014517163 @default.
• W2216193733 cites W2015609239 @default.
• W2216193733 cites W2032338421 @default.
• W2216193733 cites W2033904613 @default.
• W2216193733 cites W2055489797 @default.
• W2216193733 cites W2061391029 @default.
• W2216193733 cites W2063603944 @default.
• W2216193733 cites W2085275588 @default.
• W2216193733 cites W2101281436 @default.
• W2216193733 cites W2102150307 @default.
• W2216193733 cites W2106179110 @default.
• W2216193733 cites W2107614745 @default.
• W2216193733 cites W2114356567 @default.
• W2216193733 cites W2120097440 @default.
• W2216193733 cites W2123036728 @default.
• W2216193733 cites W2130426558 @default.
• W2216193733 cites W2134646316 @default.
• W2216193733 cites W2137903855 @default.
• W2216193733 cites W2146095678 @default.
• W2216193733 cites W2150920264 @default.
• W2216193733 cites W2161962336 @default.
• W2216193733 cites W2164079069 @default.
• W2216193733 cites W2164481004 @default.
• W2216193733 cites W2167591227 @default.
• W2216193733 cites W2183704171 @default.
• W2216193733 cites W2410019269 @default.
• W2216193733 cites W2917837889 @default.
• W2216193733 cites W827525883 @default.
• W2216193733 doi "https://doi.org/10.2967/jnumed.115.167924" @default.
• W2216193733 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/26719378" @default.
• W2216193733 hasPublicationYear "2015" @default.
• W2216193733 type Work @default.
• W2216193733 sameAs 2216193733 @default.
• W2216193733 citedByCount "31" @default.
• W2216193733 countsByYear W22161937332016 @default.
• W2216193733 countsByYear W22161937332017 @default.
• W2216193733 countsByYear W22161937332018 @default.
• W2216193733 countsByYear W22161937332019 @default.
• W2216193733 countsByYear W22161937332020 @default.
• W2216193733 countsByYear W22161937332021 @default.
• W2216193733 countsByYear W22161937332022 @default.
• W2216193733 countsByYear W22161937332023 @default.
• W2216193733 crossrefType "journal-article" @default.
• W2216193733 hasAuthorship W2216193733A5001104996 @default.
• W2216193733 hasAuthorship W2216193733A5004896348 @default.
• W2216193733 hasAuthorship W2216193733A5010336803 @default.
• W2216193733 hasAuthorship W2216193733A5025270532 @default.
• W2216193733 hasAuthorship W2216193733A5032874414 @default.
• W2216193733 hasAuthorship W2216193733A5034845779 @default.
• W2216193733 hasAuthorship W2216193733A5056053058 @default.
• W2216193733 hasAuthorship W2216193733A5065124597 @default.
• W2216193733 hasAuthorship W2216193733A5072942807 @default.
• W2216193733 hasAuthorship W2216193733A5077599099 @default.
• W2216193733 hasAuthorship W2216193733A5083617985 @default.
• W2216193733 hasBestOaLocation W22161937331 @default.
• W2216193733 hasConcept C126322002 @default.
• W2216193733 hasConcept C142724271 @default.
• W2216193733 hasConcept C204232928 @default.
• W2216193733 hasConcept C2776256026 @default.
• W2216193733 hasConcept C2777714996 @default.
• W2216193733 hasConcept C2780849966 @default.
• W2216193733 hasConcept C2781069245 @default.
• W2216193733 hasConcept C2989005 @default.
• W2216193733 hasConcept C58471807 @default.
• W2216193733 hasConcept C71924100 @default.
• W2216193733 hasConceptScore W2216193733C126322002 @default.
• W2216193733 hasConceptScore W2216193733C142724271 @default.
• W2216193733 hasConceptScore W2216193733C204232928 @default.
• W2216193733 hasConceptScore W2216193733C2776256026 @default.
• W2216193733 hasConceptScore W2216193733C2777714996 @default.
• W2216193733 hasConceptScore W2216193733C2780849966 @default.
• W2216193733 hasConceptScore W2216193733C2781069245 @default.
• W2216193733 hasConceptScore W2216193733C2989005 @default.
• W2216193733 hasConceptScore W2216193733C58471807 @default.
• W2216193733 hasConceptScore W2216193733C71924100 @default.
• W2216193733 hasIssue "5" @default.

• next